Revenue
2019
2020
2021
2022
2023
2024
2025
Hims & Hers Health, Inc. (HIMS)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.0M | $526.9M | $271.9M | $148.8M | $82.6M |
| Gross profit | $1.73B | $1.17B | $714.9M | $408.7M | $204.5M | $109.5M | $44.6M |
| Operating expenses | $1.63B | $1.11B | $744.4M | $477.4M | $319.5M | $124.6M | $119.0M |
| Operating income | $105.6M | $61.9M | −$29.5M | −$68.7M | −$115.0M | −$15.1M | −$74.4M |
| EBITDAderived | $160.1M | $79.0M | −$19.9M | −$61.2M | −$111.0M | −$14.1M | −$74.2M |
| Net income | $128.4M | $126.0M | −$23.5M | −$65.7M | −$107.7M | −$18.1M | −$72.1M |
| Basic EPSper diluted share | $0.57 | $0.58 | -$0.11 | -$0.32 | -$0.58 | -$0.51 | -$2.07 |
| Diluted EPSper diluted share | $0.51 | $0.53 | -$0.11 | -$0.32 | -$0.58 | -$0.51 | -$2.07 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026Form 4 · 10b5-1 | Okupe OluyemiChief Financial Officer | SellClass A Common Stock | 18.2K | $34.03 | $619.2K | 284.3K |
| Jun 18, 2026Form 4 · 10b5-1 | Carroll Patrick HarrisonChief Medical Officer | SellClass A Common Stock | 23.7K | $35.00 | $830.4K | 181.9K |
| Jun 17, 2026Form 4 · 10b5-1 | Chi MichaelChief Operating Officer | SellClass A Common Stock | 14.0K | $31.50 | $441.9K | 432.1K |
| Jun 17, 2026Form 4 · 10b5-1 | Becklund IrenePAO | SellClass A Common Stock | 4.5K | $31.50 | $141.4K | 6.8K |
| Jun 17, 2026Form 4 · 10b5-1 | Elshenawy MohamedCTO | SellClass A Common Stock | 30.0K | $31.50 | $946.3K | 101.0K |